Heuking Kühn Lüer Wojtek advises shareholders of medtech company Acti-Med AG on sale to Gilde Healthcare

A team led by private equity lawyer Dr. Andreas Lenz, Partner at the Cologne office, advised the shareholders of medtech company Acti-Med AG on the sale of all shares to an acquisition vehicle of private equity investor Gilde Healthcare.
 
Acti-Med AG was founded in 1997 and is headquartered in Freiensteinau. Acti-Med manufactures and develops tailor-made cannulas and cannula systems for pharmaceutical and medical applications, jointly developed with international OEMs and is one of the world’s leading suppliers in this field. Acti-Med operates a wholly owned subsidiary in Kozerkí (Poland).
 
Gilde Healthcare is a leading international investor in healthcare and pharmaceuticals, managing over EUR 1.4 billion across two fund strategies, Private Equity and Venture & Growth Capital. The Private Equity fund invests in profitable European lower mid-market healthcare companies with a prime focus on the Benelux and DACH regions. It targets healthcare providers, suppliers of medical products, and service providers in the healthcare market. The Venture & Growth Capital fund invests in medtech, healthtech, and therapeutics.
 
The sale was part of a structured sales process.

Counsel to Acti-Med AG
Heuking Kühn Lüer Wojtek: 
Dr. Andreas Lenz (Lead, M&A),
Bastian Rieck, 
Dr. Vera Randel,
Dr. Christoph Schork, LL.M. (all Corporate/M&A),
Kerstin Deiters, LL.M., EMBA (Employment, Pensions),
Dr. Verena Hoene, LL.M. (University of Washington),
Kai Oliver Runkel (both IT, Data Protection, IP), all Cologne
Christoph Wagner (Berlin, Medicinal Products; Corporate), Berlin
 
Counsel in Polish law
bnt Neupert Zamorska & Partnerzy Sp.J., Warsaw:
Dominika Wagrodzka (Lead Poland, Corporate/M&A),
Kamil Kucharski (Corporate, Commercial),
Katarzyna Harna (Employment, Pensions)